Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Humphreys

Showing results (241-250 of 272) with videos related to

Pageof 28
Sort By:
The Journal of Rheumatology|December 19, 1998
Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndromeS Yamachika, J M Nanni, K H Nguyen, et al.
The American Journal of Tropical Medicine and Hygiene|April 17, 2001
The incubation period of hantavirus pulmonary syndromeJ C Young, G R Hansen, T K Graves, et al.
International Journal of Toxicology|January 7, 2017
In Vitro Metabolite Formation in Human Hepatocytes and Cardiomyocytes and Metabolism and Tissue Distribution in Monkeys of the 2'-C-Methylguanosine Prodrug BMS-986094 : Potential Role in Clinical Cardiovascular ToxicityWenying Li, Kevin J Trouba, Li Ma, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Metabolism and disposition of [14C]BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor, after oral administration to humansLisa J Christopher, Haizheng Hong, Blisse J Vakkalagadda, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
(D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagoguesJun Li, Stephanie Y Chen, Brian J Murphy, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain InhibitorsMichael A Clegg, Natalie H Theodoulou, Paul Bamborough, et al.
Biotechniques|April 1, 1996
Competitive RNA templates for detection and quantitation of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCRR W Tarnuzzer, S P Macauley, W G Farmerie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2018
Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics StudyBhagwat Prasad, Deepak Kumar Bhatt, Katherine Johnson, et al.
Journal of Medicinal Chemistry|November 7, 2000
Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effectsK S Kim, J S Sack, J S Tokarski, et al.
Journal of Medicinal Chemistry|January 3, 1997
Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivityG C Rovnyak, S Z Ahmed, C Z Ding, et al.
Pageof 28

Showing results (241-250 of 272) with videos related to

Sort By:
Pageof 28
The Journal of Rheumatology|December 19, 1998
Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndromeS Yamachika, J M Nanni, K H Nguyen, et al.
The American Journal of Tropical Medicine and Hygiene|April 17, 2001
The incubation period of hantavirus pulmonary syndromeJ C Young, G R Hansen, T K Graves, et al.
International Journal of Toxicology|January 7, 2017
In Vitro Metabolite Formation in Human Hepatocytes and Cardiomyocytes and Metabolism and Tissue Distribution in Monkeys of the 2'-C-Methylguanosine Prodrug BMS-986094 : Potential Role in Clinical Cardiovascular ToxicityWenying Li, Kevin J Trouba, Li Ma, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Metabolism and disposition of [14C]BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor, after oral administration to humansLisa J Christopher, Haizheng Hong, Blisse J Vakkalagadda, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
(D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagoguesJun Li, Stephanie Y Chen, Brian J Murphy, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain InhibitorsMichael A Clegg, Natalie H Theodoulou, Paul Bamborough, et al.
Biotechniques|April 1, 1996
Competitive RNA templates for detection and quantitation of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCRR W Tarnuzzer, S P Macauley, W G Farmerie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2018
Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics StudyBhagwat Prasad, Deepak Kumar Bhatt, Katherine Johnson, et al.
Journal of Medicinal Chemistry|November 7, 2000
Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effectsK S Kim, J S Sack, J S Tokarski, et al.
Journal of Medicinal Chemistry|January 3, 1997
Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivityG C Rovnyak, S Z Ahmed, C Z Ding, et al.
Pageof 28